PGX

Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System

Product code
PGX
Device name
Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
Device class
Class 2
21 CFR
21 CFR 866.2680
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
2
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
15 (all years; only the last 3 years are listed here)

FDA classification definition

An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2026-08-28.

NumberDecision dateApplicantDevice nameSummary
K2600472026-08-28Roche Molecular Systems, Inc.cobas Strep A Nucleic acid test for use on the cobas…PDF
K2603332026-06-15Diasorin Molecular, LLCLIAISON NES Group A Strep; LIAISON NES Group A Strep…PDF

2 summaries are archived here for direct download.

Official FDA classification page: PGX
Classification and pathway per current FDA publications. Data from openFDA (CC0).